A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic
Abstract Background The coronavirus pandemic (Covid-19) presents a variety of challenges for ongoing clinical trials, including an inevitably higher rate of missing outcome data, with new and non-standard reasons for missingness. International drug trial guidelines recommend trialists review plans f...
| Үндсэн зохиолчид: | , , , , |
|---|---|
| Формат: | Өгүүллэг |
| Хэл сонгох: | English |
| Хэвлэсэн: |
BMC
2020-08-01
|
| Цуврал: | BMC Medical Research Methodology |
| Нөхцлүүд: | |
| Онлайн хандалт: | http://link.springer.com/article/10.1186/s12874-020-01089-6 |